Role of Nanotechnology in the Management of Rheumatoid Arthritis
Abstract
Rheumatoid arthritis (RA) is a debilitating autoimmune disease characterised by chronic inflammation of synovial joints, resulting in pain, stiffness and potential joint and bone damage. Left untreated, RA significantly impacts daily life and may lead to severe disability or death. Early diagnosis is critical to curbing disease progression and reducing inflammation and joint damage. Traditional drug therapies, although effective, often pose severe side effects, prompting interest in alternative and complementary approaches. Nanotechnology, particularly nanoparticles, has emerged as a transformative tool in RA management, offering enhanced drug delivery, improved diagnostic precision and reduced systemic side effects. This review explores the multifaceted role of nanotechnology in RA diagnosis and treatment, emphasising the synergistic potential of nanomedicine and natural compounds. Existing knowledge gaps and future research directions in leveraging nanotechnology for RA treatment are also discussed.
References
Ostrowska M, Maśliński W, Prochorec-Sobieszek M, Nieciecki M, Sudoł-Szopińska I. Cartilage and bone damage in rheumatoid arthritis. Reumatologia. 2018;56(2):111-20. doi: 10.5114/reum.2018.75523.
Vallerand IA, Patten SB, Barnabe C. Depression and the risk of rheumatoid arthritis. Curr Opin Rheumatol. 2019 May;31(3):279-84. doi: 10.1097/BOR.0000000000000597.
Ghoshal UC, Baba CS, Ghoshal U, Alexander G, Misra A, Saraswat VA, et al. Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture. Indian J Gastroenterol. 2017 Sep;36(5):390-399. doi: 10.1007/s12664-017-0797-6.
Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017 Feb;31(1):3-18. doi: 10.1016/j.berh.2017.08.003.
Dolati S, Sadreddini S, Rostamzadeh D, Ahmadi M, Jadidi-Niaragh F, Yousefi M. Utilization of nanoparticle technology in rheumatoid arthritis treatment. Biomed Pharmacother. 2016 May;80:30-41. doi: 10.1016/j.biopha.2016.03.004.
Dwivedi SD, Bhoi A, Pradhan M, Sahu KK, Singh D, Singh MR. Role and uptake of metal-based nanoconstructs as targeted therapeutic carriers for rheumatoid arthritis. 3 Biotech. 2024 May;14(5):142. doi: 10.1007/s13205-024-03990-z.
Gabr SA, Alghadir AH, Ghoniem GA, Zhang X, Choe Y, Park Y, et al. Regulation of cartilage and inflammatory biomarkers in rheumatoid arthritis patients treated with green tea therapy. African J Pharm Pharmacol. 2014;8(10):263-73. doi: 10.5897/AJPP2013.3710.
Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. QJM. 2001 Jun;94(6):309-19. doi: 10.1093/qjmed/94.6.309.
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018 Apr 27;6:15. doi: 10.1038/s41413-018-0016-9.
Jahid M, Khan KU, Rehan-Ul-Haq, Ahmed RS. Overview of rheumatoid arthritis and scientific understanding of the disease. Mediterr J Rheumatol. 2023 Aug 1;34(3):284-91. doi: 10.31138/mjr.20230801.oo.
Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, et al. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2020 Jun;79(6):744-59. doi: 10.1136/annrheumdis-2019-216656.
Li Y, Liang Q, Zhou L, Liu J, Liu Y. Metal nanoparticles: a platform integrating diagnosis and therapy for rheumatoid arthritis. J Nanoparticle Res. 2022;24(4):84. doi: 10.1007/s11051-022-05469-5.
Metselaar JM, Storm G. Liposomes in the treatment of inflammatory disorders. Expert Opin Drug Deliv. 2005 May;2(3):465-76. doi: 10.1517/17425247.2.3.465.
Nasra S, Bhatia D, Kumar A. Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment. Nanoscale Adv. 2022 Jul 26;4(17):3479-94. doi: 10.1039/d2na00229a.
Ozbakir B, Crielaard BJ, Metselaar JM, Storm G, Lammers T. Liposomal corticosteroids for the treatment of inflammatory disorders and cancer. J Control Release. 2014 Sep 28;190:624-36. doi: 10.1016/j.jconrel.2014.05.039.
Sweeney SE, Firestein GS. Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol. 2004 Mar;36(3):372-8. doi: 10.1016/s1357-2725(03)00259-0.
Riegsecker S, Wiczynski D, Kaplan MJ, Ahmed S. Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. Life Sci. 2013 Sep 3;93(8):307-12. doi: 10.1016/j.lfs.2013.07.006.
Vanniasinghe AS, Bender V, Manolios N. The potential of liposomal drug delivery for the treatment of inflammatory arthritis. Semin Arthritis Rheum. 2009 Dec;39(3):182-96. doi: 10.1016/j.semarthrit.2008.08.004.
West S. Clinical overview of rheumatoid arthritis. In: Fisher A, Lee JS, Eds. Lung disease in rheumatoid arthritis. Berlin: Springer 2018; pp. 1-18. doi: 10.1007/978-3-319-68888-6_1.
Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA. Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert Rev Clin Immunol. 2022 Sep;18(9):923-31. doi: 10.1080/1744666X.2022.2106970.
Adib-Hajbaghery M, Rafiee S. Medicinal plants use by elderly people in Kashan, Iran. urs Midwifery Stud 2018;7:67-73. doi: 10.4103/nms.nms_109_17.
Lindler BN, Long KE, Taylor NA, Lei W. Use of herbal medications for treatment of osteoarthritis and rheumatoid arthritis. Medicines (Basel). 2020 Oct 28;7(11):67. doi: 10.3390/medicines7110067.
Emerich DF, Thanos CG. Nanotechnology and medicine. Expert Opin Biol Ther. 2003 Jul;3(4):655-63. doi: 10.1517/14712598.3.4.655.
Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: Emerging carriers for drug delivery. Saudi Pharm J. 2011 Jul;19(3):129-41. doi: 10.1016/j.jsps.2011.04.001.
Marulli E, Aloisi A, Di Giuseppe P, Rinaldi R. Micro and nanotechnology for early diagnosis and detection of rheumatic diseases-molecular markers. BioChip Journal. 2016 Sep;10:189-97. doi: 10.1007/s13206-016-0305-6.
Zhao J, Chen X, Ho KH, Cai C, Li CW, Yang M, et al. Nanotechnology for diagnosis and therapy of rheumatoid arthritis: Evolution towards theranostic approaches. Chinese chemical letters. 2021 Jan 1;32(1):66-86. doi: 10.1016/j.cclet.2020.11.048.
Zheng M, Jia H, Wang H, Liu L, He Z, Zhang Z, et al. Application of nanomaterials in the treatment of rheumatoid arthritis. RSC Adv. 2021 Feb 10;11(13):7129-37. doi: 10.1039/d1ra00328c.
Tavasolian F, Moghaddam AS, Rohani F, Abdollahi E, Janzamin E, Momtazi-Borojeni AA, et al. Exosomes: Effectual players in rheumatoid arthritis. Autoimmun Rev. 2020 Jun;19(6):102511. doi: 10.1016/j.autrev.2020.102511.
Tang TT, Lv LL, Wang B, Cao JY, Feng Y, Li ZL, et al. Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone: an efficient therapeutic strategy against renal inflammation and fibrosis. Theranostics. 2019 Jul 9;9(16):4740-55. doi: 10.7150/thno.33520.
Gallelli L, Colosimo M, Pirritano D, Ferraro M, De Fazio S, Marigliano NM, et al. Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Investig. 2007;27(2):115-22. doi: 10.2165/00044011-200727020-00004.
Chiou SK, Mandayam S. NSAIDs enhance proteasomic degradation of survivin, a mechanism of gastric epithelial cell injury and apoptosis. Biochem Pharmacol. 2007 Nov 15;74(10):1485-95. doi: 10.1016/j.bcp.2007.07.024.
van der Velde G, Pham B, Machado M, Ieraci L, Witteman W, Bombardier C, Krahn M. Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken). 2011 Jan;63(1):65-78. doi: 10.1002/acr.20338.
Mittal V, Barak A, Sharma A, Singhal A. Nature's Pharmacy: Herbal interventions in rheumatoid arthritis treatment: a comprehensive review. Curr Rheumatol Rev. 2024 Apr 25. doi: 10.2174/0115733971294467240326074155.
Lee WS, Lim JH, Sung MS, Lee EG, Oh YJ, Yoo WH. Ethyl acetate fraction from Angelica sinensis inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and COX-2, PGE2, and MMPs production. Biol Res. 2014 Sep 5;47(1):41. doi: 10.1186/0717-6287-47-41.
Almulathanon AA, Sideek Tawffiq Z. a promising role of cinnamon towards rheumatoid arthritis. MMSL. 2023 Sep 1;92(3):226-34. doi: 10.31482/mmsl.2022.043.
Kou H, Huang L, Jin M, He Q, Zhang R, Ma J. Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis. Front Immunol. 2023 May 31;14:1121655. doi: 10.3389/fimmu.2023.1121655.
Zhu L, Zhang Z, Xia N, Zhang W, Wei Y, Huang J, et al. Anti-arthritic activity of ferulic acid in complete Freund's adjuvant (CFA)-induced arthritis in rats: JAK2 inhibition. Inflammopharmacology. 2020 Apr;28(2):463-73. doi: 10.1007/s10787-019-00642-0.
Alanazi HH, Elfaki E. The immunomodulatory role of withania somnifera (L.) dunal in inflammatory diseases. Front Pharmacol. 2023 Feb 22;14:1084757. doi: 10.3389/fphar.2023.1084757.
Balkrishna A, Solleti SK, Singh H, Sharma N, Varshney A. Withanolides from Withania somnifera ameliorate neutrophil infiltration in endotoxin-induced peritonitis by regulating oxidative stress and inflammatory cytokines. Planta Med. 2022 May;88(6):466-78. doi: 10.1055/a-1438-2816.
Said R, Jadhav SL, Kamble SC. Tinospora cordifolia a Medicinal plant with many roles: A Review. Res J Pharmacog Phytochem. 2023;15(1):87-90. doi: 10.52711/0975-4385.2023.00013.
Cahyono B, Suzery M, Amalina ND. Anti-inflammatory effect of Alpinia galanga extract on acute inflammatory cell model of peripheral blood mononuclear cells stimulated with TNF-α. Med Glas (Zenica). 2023 Aug 1;20(2). doi: 10.17392/1561-23.
Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, et al. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol. 2012 Feb;12(2):368-77. doi: 10.1016/j.intimp.2011.12.009.
Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999 Sep 15;163(6):3474-83. PMID: 10477620.
Meng Z, Yan C, Deng Q, Gao DF, Niu XL. Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol Sin. 2013 Jul;34(7):901-11. doi: 10.1038/aps.2013.24.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).